459 related articles for article (PubMed ID: 37518857)
21. Smart Nanocarriers for the Delivery of Nucleic Acid-Based Therapeutics: A Comprehensive Review.
Ramasamy T; Munusamy S; Ruttala HB; Kim JO
Biotechnol J; 2021 Feb; 16(2):e1900408. PubMed ID: 32702191
[TBL] [Abstract][Full Text] [Related]
22. Clinical applications of nanomedicines in lung cancer treatment.
Norouzi M; Hardy P
Acta Biomater; 2021 Feb; 121():134-142. PubMed ID: 33301981
[TBL] [Abstract][Full Text] [Related]
23. Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?
Nerone M; Grande MD; Sessa C; Colombo I
Explor Target Antitumor Ther; 2022; 3(2):149-171. PubMed ID: 36046840
[TBL] [Abstract][Full Text] [Related]
24. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
25. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
27. A Comprehensive Overview of circRNAs: Emerging Biomarkers and Potential Therapeutics in Gynecological Cancers.
Ma Y; Zheng L; Gao Y; Zhang W; Zhang Q; Xu Y
Front Cell Dev Biol; 2021; 9():709512. PubMed ID: 34368160
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles for Effective Combination Therapy of Cancer.
Jadia R; Scandore C; Rai P
Int J Nanotechnol Nanomed; 2016; 1(1):. PubMed ID: 28540369
[TBL] [Abstract][Full Text] [Related]
29. Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.
Engelberth SA; Hempel N; Bergkvist M
Crit Rev Oncog; 2014; 19(3-4):281-315. PubMed ID: 25271436
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy.
Singh B; Yang S; Krishna A; Sridhar S
Front Chem; 2020; 8():594619. PubMed ID: 33330383
[TBL] [Abstract][Full Text] [Related]
31. Emerging nanomedicines of paclitaxel for cancer treatment.
Chen Q; Xu S; Liu S; Wang Y; Liu G
J Control Release; 2022 Feb; 342():280-294. PubMed ID: 35016919
[TBL] [Abstract][Full Text] [Related]
32. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
33. RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer.
Haque S; Cook K; Sahay G; Sun C
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683988
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicines for the treatment of hematological malignancies.
Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
[TBL] [Abstract][Full Text] [Related]
35. Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies.
Shigdar S; Ward AC; De A; Yang CJ; Wei M; Duan W
Br J Haematol; 2011 Oct; 155(1):3-13. PubMed ID: 21810089
[TBL] [Abstract][Full Text] [Related]
36. New Insights on Ferroptosis and Gynecological Malignancies.
Fan R; Sun Y; Wang M; Wang Q; Jiang A; Yang T
Front Mol Biosci; 2022; 9():921298. PubMed ID: 35775079
[TBL] [Abstract][Full Text] [Related]
37. Antibody-Incorporated Nanomedicines for Cancer Therapy.
Wu SY; Wu FG; Chen X
Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
[TBL] [Abstract][Full Text] [Related]
38. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis.
Zhang N; Liu C; Di W
Onco Targets Ther; 2023; 16():545-558. PubMed ID: 37448551
[TBL] [Abstract][Full Text] [Related]
39. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
40. Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment.
Berghuis AY; Pijnenborg JFA; Boltje TJ; Pijnenborg JMA
Int J Cancer; 2022 Feb; 150(4):678-687. PubMed ID: 34741527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
